At a glance
- Originator Roche Palo Alto LLC
- Class Analgesics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 09 Nov 2006 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 21 Dec 1999 New profile
- 21 Dec 1999 Preclinical development for Neuropathic pain in USA (Unknown route)